HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of congenital chylous ascites with a somatostatin analogue.

Abstract
Congenital chylous ascites (CCA) results from maldevelopment of the intra-abdominal lymphatic system. Newborns present with respiratory distress and abdominal distention. Medical treatment of CCA is often prolonged. A newborn with CCA was treated with octreotide, a somatostatin analogue, resulting in rapid and complete resolution of the ascites.
AuthorsM G Caty, M L Hilfiker, R G Azizkhan, P L Glick
JournalPediatric surgery international (Pediatr Surg Int) Vol. 11 Issue 5-6 Pg. 396-7 (Jun 1996) ISSN: 0179-0358 [Print] Germany
PMID24057727 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: